The insulin receptor on the human lymphocyte: Insulin-induced down-regulation of 126,000 and 90,000 glycosylated subunits

Diabetologia, Apr 1982

Cultured human lymphoblastoid B lymphocytes were surface-labelled with iodine125 and solubilized in 1% Triton X-100 in the presence of protease inhibitors. After purification of labelled glycoproteins by elution from immobilized wheat germ leetin with 0.3 mol/l N-acetyl-D-glucosamine, insulin receptors were quantitatively immunoprecipitated using IgG receptor auto-antibodies. The overall recovery of labelled glycoprotein was 0.02–0.04%; analysis by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and autoradiography under reducing conditions revealed two major bands with molecular weights of 126,000 and 90,000, and a minor band of 67,000 daltons. The mobilities of both major receptor subunits were increased after treatment with neuraminidase. When lymphocyte receptor binding was ‘down-regulated’ before surface labelling, there was a concomitant decrease in the recovery of both the 126,000 and 90,000 subunits. These data indicate that ‘down-regulation’ of binding probably involves degradation of the receptor molecule.

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://link.springer.com/content/pdf/10.1007%2FBF00281297.pdf

The insulin receptor on the human lymphocyte: Insulin-induced down-regulation of 126,000 and 90,000 glycosylated subunits

Diabetologia The Insulin Receptor on the Human Lymphocyte: Insulin-Induced Down-Regulation of 126,000 and 90,000 Glycosylated Subunits L. C. Harrison 0 1 A. Itin 0 1 M. K a s u g a 0 1 E. Van O b b e r g h e n 0 1 Surface Labellingof IM- 0 1 Lymphocytes 0 1 0 Porcine insulin (27.3 U/rag, lot QA 1312)was purchased from EI- anco Products (Eli Lilly , Indianapolis, Indiana, USA); carrier free Na 125Iand Triton X-100 from New England Nuclear, Boston, Massachusets, USA; lactoperoxidase (E.C.1.11.1.7)purified from milk (lot 39C-0108),leupeptin (lot 109C0335),phenylmethyl sulphonylftuoride,aprotonin (lot 10F0562)and 4-(2-hydroxyethyl)-lpiperazine ethane sulphonic acid (Hepes) from Sigma, St. Louis, Missouri, USA; Bacitracin (lot 800695) from Calbiochem, San Diego, California; neuraminidase (E.C.3.2.1.19,lot 56E542)from Worthington, Freehold, New Jersey , USA; human IgG and wheat germ lectin-agarose from Miles-Yeda , Kankakee, Illinois , USA; and Protein A-Sepharose from Pharmacia , Piscataway,New Jersey, USA. Fetal calf serum and RPM 1-1640media werefrom Flow Laboratories, McLean, Virginia , USA; Antiserum to human IgG was raised in sheepto a titre of2.5 mg/ml. Reagentgrade chemicals for sodium dodecyl sulphate-polyacrylamidegel electrophoresis (SDS-PAGE) were all purchased from Bio-Rad , Richmond, California , USA. Kodak XR-2 film and Dupont Cronex Lighting-Plus X-rayenhancingscreenswerepurchased from PickerCorporation , White Plains, New Jersey 1 Diabetes Branch, National Institute of Arthritis, Metabolismand DigestiveDiseases, National Institutes of Health , Bethesda, Maryland , USA 0 0 1 2 - 1 8 6 X / 8 2 / 0 0 2 2 / 0 2 3 3 / $ 0 1 . 2 0 H u m a n lymphocytes; surface labelling; insulin receptors; auto-antibodies; r e c e p t o r subunits 9 Springer-Verlag 1982 Summary. C u l t u r e d h u m a n l y m p h o b l a s t o i d B lymphocytes were surface-labelled with iodine 125and solubilized in 1% Triton X-100 in the presence o f protease inhibitors. After purification o f labelled glycoproteins by elution f r o m immobilized wheat germ lectin with 0.3 m o l / l N-acetyl-D-glucosamine, insulin receptors were quantitatively i m m u n o p r e c i p i t a t e d using I g G receptor auto-antibodies. The overall recovery o f labelled glycoprotein was 0.02-0.04%; analysis by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and a u t o r a d i o g r a p h y u n d e r reducing conditions revealed two m a j o r bands with m o l e c u l a r weights o f 126,000 and 90,000, and a m i n o r b a n d o f 67,000 daltons. The mobilities o f b o t h major r e c e p t o r subunits were increased after treatment with neuraminidase. W h e n l y m p h o c y t e r e c e p t o r binding was 'down-regulated' before surface labelling, there was a c o n c o m i t a n t decrease in the recovery o f b o t h the 126,000 and 90,000 subunits. These data indicate that 'down-regulation' o f binding p r o b a b l y involves degradation o f the r e c e p t o r molecule. The structure o f the insulin receptor in rat tissues has b e e n analysed after covalent affinity labelling, either by chemical cross-linking o f 125I-insulin [ 1, 2 ] or b y binding o f photoreactive 125I-insulins [ 3-6 ]. These studies reveal a disulphide-linked oligomer o f molecular weight 300-350,000, a m a j o r r e d u c e d - b i n d i n g subunit o f 125-135,000, and a variable subunit o f 90,000. We have utilized polyclonal auto-antibodies to the insulin receptor, o b t a i n e d from patients with severe insulin-resistant diabetes and the skin disorder acanthosis nigricans [ 7, 8 ] as probes o f receptor function. Recently it was d e m o n s t r a t e d directly that these auto-antibodies recognise the insulin binding subunits o f the disulphide-linked oligomeric receptor [9]. In the present study we have used these auto-antibodies to isolate receptor subunits f r o m ~2sI-surface-labelled h u m a n lymphocytes and to examine the fate o f these subunits after 'down-regulation' o f insulin binding. Materials and Methods Human Blymphoblastoidcellsofthe IM-9 line weregrownin continuous culture at 37~ in RPM11640medium supplementedwith 10%fetal calf serum, 25 mmol/1 Hepes, and 2 retool/1 glutamine. After washing three times in phosphate buffered saline (pH 7.5, PBS),the cellswere iodinated as previouslydescribed [ 10 ].Briefly, 100ml of PBS,at 24~C, contained approximately I x 106cells/ml, 5 10.7 tool/1 Nal, Na I25I(1 mCi),and lactoperoxidase(2 rag),to L. C. Harrison et al. :'Down-Regulation' of Insulin Receptor Subunits in Lymphocytes which 100 p,1 of 10-3 mol/l H 2 0 2 w a s added every minute for 15 min. The cells were then washed three times with PBS and their viability assessed by Trypan blue exclusion (always > 90%). The validity of this iodination technique for the lymphocyte cell surface has been established [ 10 ]. Down-Regulation of Lymphocyte Insulin Binding Before surface labelling, cells were divided into three batches each of approximately 108 cells in culture medium, and incubated either with no addition, with 10-8 mol/1 insulin, or with 10-6 tool/1 insulin. After 12 h at 37 ~ the cells were centrifuged at 600 x g and given three 30 rain washes in PBS containing 0.1% bovine serum albumin. This washing technique has been shown to displace residual bound insulin [11]. The cells were then resuspended in PBS (100 ml), aliquots were taken for the measurement of 125I-insulin binding, and the remaining cells were suface-labelled. Insulin Binding Insulin was iodinated to a specific activity of 120-140 gCi/lxg using carrier-free Na 125Iand a modification of the chloramine T technique [ 12 ]. In the binding assay, a tracer amount of 12sI-insulin (10,000 cpm; 40 pg) was incubated with approximately 106 cells in 1 ml of PBS for 45 min at 24 ~ in triplicate. Parallel incubations contained, in addition, 50 ag of unlabelled insulin in order to determine non-displaceable ('non-specific') radioactivity, which was subsequently subtracted from the total amount bound to give the specific bound value. Cells were precipitated by centrifugation at 4 ~C in a Beckman Microfuge, washed once by resuspension in cold PBS, and finally re-precipitated and counted in a gamma spectrometer. Solubilization of Cells After surface labelling, cells were pelleted and stirred for 1 h at 24 ~C with PBS (5 ml) containing 1% (v/v) Triton X-100 and the following serine or thiol protease inhibitors: phenylmethyl sulphonylfluoride (10 -5 mol/l) leupeptin (10 ~tg/ml) and aprotonin (5 x 102 kallikrein inhibitory units/ml). These protease inhibitors were included in all subsequent procedures. The mixture was then centrifuged at 105,000 x g for 90 min at 3 ~C, and the insoluble pellet discarded. The recovery of solubilized labelled protein was - 90% and it has been shown previously that labelled protein reflects the content of insulin binding sites [ 10 ]. Wheat Germ Lectin Chromatography A column of wheat germ lectin-agarose (0.9 x 3.0 cm) was washed in turn with 100 ml each of 0.3 tool/1 N-acetyl-D-glucosamine in 50 mmol/l Hepes; 0.1% SDS in 50 mmol/l Hepes; and a solution containing 0.15 mol/l NaC1, 10 mmol/l MgSO4, 50 mmol/l Hepes and 0.1% Triton X-100. Solubilized labelled cells were cycled through the column four times at 24 ~ and the final eluate discarded. The column was washed with 60 ml of 0.15 tool/1 NaC1, 10 mmol/1 MgSO4, 50 mmol/1 Hepes, 0.1% Triton X-100. Bound glycoproteins were eluted by the application of 6 ml of 0.3 mol/l Nacetyl-D-glucosamine in 50 retool/1 Hepes containing 0.025% Triton X-100 (pH 7.5). The eluate was concentrated fourfold on an Amicon PM-10 membrane, stored at 4 ~ and used for the immunoprecipitation studies within 3 days. We have shown that elution of glycoproteins from wheat germ lectin results in a 20-fold purification of the insulin receptor with almost complete recovery, and separation of the receptor from insulin degrading activity [ 13 ]. Immunoprecipitation of Insulin Receptors Wheat germ lectin-purified glycoproteins were immunoprecipitated using receptor auto-antibodies as described previously [ 10, 14 ]. The receptor antibodies were obtained from the serum of a patient with the syndrome of severe insulin resistance and acanthosis nigricans [ 7, 15 ]. Their specificity for the insulin receptor has been documented by several criteria [ 8 ],including the demonstration that they bind to the same receptor subunits as insulin [ 9 ]. IgG fractions from the serum of this patient and from pooled control sera were purified by acid desorption from Protein A-Sepharose [ 16 ]. Purified labelled glycoproteins (approximately 5 x 106 cpm, in a volume of I ml) were incubated for 4 h at 4 ~C with control IgG (200 ttg), with or without anti-receptor IgG (10 ug). Sheep anti-human IgG (titre 2.5 mg/ml, 100 Ixl,containing protease inhibitors) was added and the incubation allowed to proceed for a further 18 h at 4 ~ After centrifugation in a Beckman Microfuge, the precipitates were washed twice with 50 mmol/1 Hepes-0.1% Triton buffer and immediately counted in a gamma spectrometer. Specific precipitation of ~2SI-receptor was assumed to represent the difference between radioactivity precipitated by anti-receptor IgG from the patient with insulin resistance and that precipitated or trapped by control IgG. Sodium Dodeeyl Sulphate-Polyacrylamide Gel Electrophoresis and Autoradiography The radioactive pellets were solubilized by boiling for 5 rain in 2% SDS and 5% mercaptoethanol and electrophoresed [ 17 ]in slab gels (8% acrylamide, 2 mm thickness) under reducing conditions (l% mercaptoethanol) in 0.1% SDS. The following molecular weight standards (Bio-Rad) were used: myosin (200,000), galactosidase (116,500), phosphorylase b (94,500), bovine serum albumin (68,000) and ovalbumin (43,000). Gels were stained overnight in a solution of 50% methanol, 10% acetic acid and 0.1% Coomassie blue, and destained by diffusion in a solution of 5% methanol, 10% acetic acid. Autoradiography of dried slab gels was performed at - 70 ~C using an enhancing screen. Results Immunoprecipitation and Analysis o f ;25I-labelled Proteins Elution from wheat germ lectin-agarose resulted in an approximately 20-fold purification of labelled glycoproteins (Fig. 1). In a typical experiment anti-receptor IgG precipitated about 25,000 c p m from 5 x 10 6 c p m of wheat germ-purified glycoproteins. After washing, non-specific precipitation or trapping by control IgG was < 6% of total counts precipitated (see also Fig. 2). The specific precipitation by anti-receptor IgG represented 0.02-0.04% of the crude starting material (Fig. 1), and can be assumed to reflect the initial receptor concentration ( ~ 1 part in 5 000), since the recoveries from wheat germ lectin [ 13, 18 ] and after i m m u n o p r e c i p i t a t i o n [14] are almost complete. Since the insulin binding capacity o f solubilized lymphocyte m e m b r a n e s is 1-2 p m o l / m g [ 10, 18 ] it can be calculated that the native receptor of molecu Na (1251)* Lactoperoxidase Triton X-100 / N-acetylglucosamine , 15-6%) ~ ~ + Receptorintibodies Anti-lgG or Protein A-Sepharose Electrophoresis and Autoradiography 5% mercaptoethanol lar weight 300-350,000 has a binding valency of at least 2. Analysis of the eluate from wheat germ lectin and of the immunoprecipitate by SDS-PAGE and autoradiography, revealed specific precipitation of two major labelled bands with molecular weights of 126,000 and 90,000, and a minor band of 67,000 (Fig. 2). Excision of the two major bands and counting in a gamma counter revealed that they contained equal amounts of radioactivity. Minor bands of 42,000 and a minor amount of low molecular weight activity ( - 20,000) were detected in the precipitates with both anti-receptor and control IgG. When the labelled glycoproteins from the wheat germ lectin column were treated with neuraminidase before immunoprecipitation, there was a small but reproducible increase in the relative mobilities of both specific bands, their apparent molecular weights decreasing from 126,000 to 120,000 and from 92,000 to 85,000 respectively (not shown). 'Down-Regulation'of ReceptorBinding Incubation of cells with insulin followed by washing causes a specific time, temperature and dose-dependent decrease in the expression of binding activity, not accounted for by residual receptor occupancy [ 11, 19, 20 ]. When cells were 'down-regulated' in this fashion, before surface labelling, subsequent immunoprecipitation always revealed a decrease in the intensity of both major subunits, compared with control non'down-regulated' ceils. This decrease appeared to be proportional to the decrease in insulin binding and was confirmed by excision and counting of the bands. In the experiment shown (Fig. 3), the recoveries of radioactivity in the 126,000 and 90,000 bands respectively, were: A 1555 cpm and 1434 cpm; B 624 cpm and 586 cpm; C 140 cpm and 96 cpm. It should be emphasised that when surface labelling was performed simply in the presence of excess insulin (10 -6 mol/l insulin preincubated with cells for 10 rain at 37 oC), L. C. Harrison et al. : 'Down-Regulation' of Insulin Receptor Subunits in Lymphocytes (Insutin) Decrease in B:F/Cett 0 0 10-Srnot/t 10-6rnot/t 67"/,, 86% followed by washing and processing as described, there was no change in the appearance of either subunit. Discussion On the basis of evidence presented here we conclude that the lymphocyte insulin receptor contains 126,000 and 90,000 subunits. The subunits are specifically precipitated by antibodies to the insulin receptor and disappear after 'down-regulation' of binding in intact cells. Both subunits must be surface glycoproteins; they are surface-labelled with 125I-, bind to wheat germ lectin, and contain sialic acid because their electrophoretic behaviour is altered by neuraminidase treatment. The coordinate loss of the subunits after insulininduced 'down-regulation' is strong evidence that 'down-regulation' is not simply due to inactivation of the binding function in situ, but presumably represents loss (e.g. endocytosis) of the subunits from the cell surface. Using a radioimmunoassay for the insulin receptor, we showed that with 'down-regulation' there was a decrease in total cellular immunoreactive receptors [ 20 ] and have also reported recently that both subunits can be 'down-regulated' after biosynthetically-labelling them with 35S-methionine [ 21 ]. These data are consistant with 'down-regulation' being due to an acceleration of receptor endocytosis and degradation [111. Other studies have identified an insulin binding site of 125-135,000 by covalent labelling of membranes with photoreactive 125I-insulin derivatives [ 3-6 ] or by chemical cross-linking of 125I-insulin [ 1, 2, 9 ]. In the studies by Yip et al. [ 3, 4 ] and ourselves [ 9 ], a second species of 90,000 was also covalently labelled. When the receptor is quantitatively purified using a sequence of either insulin and concanavalin A columns [ 5, 22 ] or wheat germ lectin and receptor antibody columns [13], major bands of 125-135,000 and 4245,000 are identified by Coomassie blue staining. In addition, after purification of the placental receptor, we detected a minor band of 90,000 whose staining intensity appeared to be inversely proportional to that of the 45,000 band, and suggested therefore that the 90,000 species may be composed of two 45,000 'domains' [131.These should not be confused with the non-specific band of approximately 42,000 seen in the present experiments. This band runs at the front boundary of the large amount of reduced IgG present and represents a labelled protein recognised by normal human IgG or sheep anti-human IgG, possibly an Fc receptor or surface immunoglobulin on the lymphocytes. The 90,000 subunit has not been uniformly detected by the covalent labelling techniques. In our hands, it was seen when increased concentrations of the chemical cross-linking reagent disuccinimidyl suberate were used [ 9 ]. However, even under these conditions, only a minority of the total available insulin receptors in membranes are covalently labelled. The results of cross-linking studies should therefore be interpreted cautiously as they may not reveal the total picture. Although the 90,000 subunit does appear to be an insulin-binding subunit, it cannot be excluded that it is an associated membrane protein with a related role (e. g., an effector molecule for signal transmission or an affinity regulator for the binding site). It is interesting to note that the target size of the functional insulin-binding site determined by radiation inactivation is consistent with a molecular weight of approximately 90,000 [ 23 ]. Despite a reasonable consensus as to the subunit composition of the insulin receptor examined in various tissues, the relationship between the subunit components, especially the lower molecular weight forms, remains to be elucidated. JaL. C. Harrison et al.: 'Down-Regulation' of Insulin Receptor Subunits in Lymphocytes cobs et al. [ 22 ] have reported that on the basis of peptide mapping the 45,000 species is not a degradation product of the 135,000 species. The 125-135,000 subunit is therefore probably not composed of 90,000 and 45,000 components. The subunit sizes found in the present study differ from those we reported previously [ 10 ]. In this earlier study, the lymphocyte receptor was resolved into components with molecular weights of 90,000, 67,000, 56,000 and 34,000; precipitation of the three larger species was reduced by pre-treatment of 125I-labelled, solubilized membranes with 10 - 6 mol/1 insulin for 16 h at 4 ~ A band of 125-135,000 was not clearly defined, but could be seen in some gel patterns even though the 11% acrylamide rod gels used were not well-suited to resolving molecules of this size. Apart from changing to a more appropriate gel system, we believe that the major reason for these differences, especially the appearance previously of apparently specific, lower molecular weight forms, was the presence of proteolysis. This has been counteracted by modifying the earlier protocol: the labelled lymphocytes were not homogenized to obtain a crude membrane fraction but directly solubilized by gentle stirring in 1% Triton; protease inhibitors were included in all buffers and in the anti-human IgG serum; and the solubilized cells were first chromatographed on a wheat germ lectin column to purify receptors and remove insulin degrading activity. Proteolysis of the native receptor during solubilization a n d / o r immunoprecipitation is probably due to 'non-specific' proteases, but could possibly also result from the action of receptorrelated proteases or specific processing steps as suggested by Seals and Czech [ 24 ]. Careful inspection of other published studies on insulin receptor purification [ 22 ] does reveal a number of lower molecular weight components similar to those we reported earlier [ 10 ]. Even in the present study, a minor specific band of 67,000 can be seen (Fig. 2). The inhibition of the precipitation of these lower molecular weight components by insulin [ 10 ] strongly suggests that they are authentic components of the larger subunits seen in the presence of protease inhibitors. Furthermore, the stoichiometry of insulin binding to the 125-135,000 subunit is unknown and it could contain more than one insulin binding site. The functional significance of two major receptor subunits is open to a number of interpretations. Both could contribute to a common binding site region in an analogous fashion to the light and heavy chains in the variable region of immunoglobulin molecules. Alternatively, they may be separate binding sites for one insulin molecule to bind bivalently or for two insulin molecules to bind to classical high and low affinity sites. We are currently attempting to determine which of these models applies. Acknowledgements.We are indebted to Dr. J. Roth without whose support these studies would have not been possible, to Dr. C. R. Kahn for his helpful comments and criticisms, and to Mrs. L. Stafford for secretarial assistance. 1. Pilch PF , Czech MP ( 1979 ) Interaction of cross-linking agents with the insulin effector system of isolated fat cells: covalent linkage of 125I-insulin to a plasma membrane receptor protein of 140,000 daltons . J Biol Chem 254:3 375 3 381 2. Pilch PF , Czech MP ( 1980 ) The subunit structure &the high affinity insulin receptor: evidence for a disulfide-linked receptor complex in fat cell and liver plasma membranes . J Biol Chem 255 : 1722 - 1731 3. Yip CC , Yeung CWT , Moule ML ( 1978 ) Photoaffinity labelling of insulin receptor of rat adipocyte plasma membrane . J Biol Chem 253 : 1743 1745 4. Yip CC , Yeung CWT , Moule ML ( 1980 ) Photoaffinity labelling of insulin receptor proteins of liver plasma membrane preparations . Biochemistry 19 : 70 - 76 5. Jacobs S , Hazum E , Shechter Y , Cuatrecasas P ( 1979 ) Insulin receptor: covalent labelling and identification of subunits . Proc Natl Acad Sci USA 76 : 49184921 6. Wisher MH , Baron MD , Jones PH , Sonksen PH , Saunders DJ , Thamm P , Brandenburg D ( 1980 ) Photoreactive insulin analogues used to characterize the insulin receptor . Biochem Biophys Res Commun 92 : 492498 7. Kahn CR , Flier JS , Bar RS , Archer JA , Gorden P , Martin MM , Roth J ( 1976 ) The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man . N Engl J Med 294 : 739 - 745 8. Harrison LC , Kahn CR ( 1980 ) Autoantibodies to the insulin receptor: clinical significance and experimental applications . Prog Clin Immunot 4 : 107 125 9. Kasuga M , Van Obberghen E , Yamada K , Harrison LC ( 1981 ) Autoantibodies against the insulin receptor recognise the insulin binding subunits of an oligomeric receptor . Diabetes 30 : 354 - 357 10. Lang U , Kahn CR , Harrison LC ( 1980 ) The subunit structure of the insulin receptor of the human lymphocyte . Biochemistry 19 : 64 - 70 I 1. Kosmakos F , Roth J ( 1980 ) Insulin-induced loss of the insulin receptor in IM-9 lymphocytes. A biological process mediated through the insulin receptor . J Biol Chem 255 : 9 860 - 9 869 12. Roth J ( 1975 ) Methods for assessing immunologic and biologic properties of iodinated peptide hormones . Methods Enzymol 37 : 223 233 13. Harrison LC , Itin A ( 1980 ) Purification of the insulin receptor from human placenta by chromatography on immobilized wheat germ lectin and receptor antibody . J Biol Chem 255 : 12066 - 12072 14. Harrison LC , Flier JS , Roth J , Karlsson FA , Kahn CR ( 1979 ) Immunoprecipitation of the insulin receptor: a sensitive assay for receptor antibodies and a specific technique for receptor purification . J Clin Endocrinol Metab 48 : 59 - 65 . 15. Flier JS , Kahn CR , Roth J , Bar RS ( 1975 ) Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance . Science 190 : 63 - 65 16. Goding JW ( 1978 ) Use of staphylococcal protein A as an immunological reagent . J Immunol Methods 20 : 241 - 253 17. Laemmli UK ( 1970 ) Cleavage of structure proteins during the assembly of the head of bacteriophage T 4 . Nature (London) 227 : 680 ~ 685 18. Hedo JA , Harrison LC , Roth J ( 1981 ) Binding of insulin receptors to lectins: evidence for common carbohydrate determinants on membrane proteins . Biochemistry 20 :3 385 - 3 392 19. Gavin JR III, Roth J , Neville Jr DM , De Meyts P , Buell DN ( 1974 ) Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture . Proc Natl Acad Sci (USA ) 71 : 84 - 88 20. Harrison LC , Flier JS , Itin A , Kahn CR , Roth J ( 1979 ) Radioimmunoassay of the insulin receptor: new probe of receptor structure and function . Science 203 : 544 - 547 21. Van Obberghen E , Kasuga M , LeCam A , Hedo J , Itin A , Harrison LC ( 1981 ) Biosynthetic labelling of insulin receptor subunits in the cultured human IM-9 lymphcyte . Proc Natl Acad Sci (USA ) 78 : 1052 - 1056 22. Jacobs S , Hazum E , Cuatrecases P ( 1980 ) The subunit structure of rat liver insulin receptor: antibodies directed against the insulin-binding subunit . J Biol Chem 255 : 6 937 - 6 940 23. Harmon JT , Kahn CR , Kempner ES , Schlegel W ( 1980 ) Characterization of the insulin receptor in its membrane environment by radiation inactivation . J Biol Chem 255 : 3 412 - 3 419 24. Seals JR , Czech MP ( 1980 ) Evidence that insulin activates an intrinsic plasma membrane protease in generating a secondary chemical mediator . J Biol Chem 255 : 6529 - 6531 Received: 6 May 1981 and in revised form: 28 August 1981 Len C. Harrison The Endocrine Laboratory Royal Melbourne Hospital Victoria 3050 , Australia


This is a preview of a remote PDF: https://link.springer.com/content/pdf/10.1007%2FBF00281297.pdf

L. C. Harrison, A. Itin, M. Kasuga, E. Van Obberghen. The insulin receptor on the human lymphocyte: Insulin-induced down-regulation of 126,000 and 90,000 glycosylated subunits, Diabetologia, 1982, 233-238, DOI: 10.1007/BF00281297